This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Amphastar Pharmaceuticals, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Kevin Xie: Innovator in Pharmaceutical Compositions
Introduction
Kevin Xie is a notable inventor based in Anaheim, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of long-term sustained release compositions for bisphosphonate drugs. His work is crucial in addressing various bone diseases, including osteoporosis.
Latest Patents
Kevin Xie holds a patent for a "Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate." This innovative composition includes an aqueous suspension of a solid that comprises a salt of a bisphosphonate drug and a salt of pentavalent phosphorus oxoacid. The patent highlights the potential of these compositions to treat a variety of bone diseases effectively.
Career Highlights
Kevin Xie is currently employed at Amphastar Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Amphastar has positioned him as a key player in the pharmaceutical industry, particularly in the area of drug formulation.
Collaborations
Some of his coworkers include Jack Yongfeng Zhang and Mary Ziping Luo, who contribute to the collaborative environment at Amphastar Pharmaceuticals.
Conclusion
Kevin Xie's innovative work in pharmaceutical compositions demonstrates his commitment to improving treatments for bone diseases. His contributions are vital to the ongoing advancements in the pharmaceutical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile